These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20954832)

  • 1. Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase.
    Vasu VT; de Cruz SJ; Houghton JS; Hayakawa KA; Morrissey BM; Cross CE; Eiserich JP
    Free Radic Res; 2011 Feb; 45(2):165-76. PubMed ID: 20954832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress in early cystic fibrosis lung disease is exacerbated by airway glutathione deficiency.
    Dickerhof N; Pearson JF; Hoskin TS; Berry LJ; Turner R; Sly PD; Kettle AJ;
    Free Radic Biol Med; 2017 Dec; 113():236-243. PubMed ID: 28982600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.
    Chapman AL; Morrissey BM; Vasu VT; Juarez MM; Houghton JS; Li CS; Cross CE; Eiserich JP
    J Cyst Fibros; 2010 Mar; 9(2):84-92. PubMed ID: 20080069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase and protein oxidation in cystic fibrosis.
    Van Der Vliet A; Nguyen MN; Shigenaga MK; Eiserich JP; Marelich GP; Cross CE
    Am J Physiol Lung Cell Mol Physiol; 2000 Sep; 279(3):L537-46. PubMed ID: 10956629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxidase activity within circulating neutrophils correlates with pulmonary phenotype in cystic fibrosis.
    Garner HP; Phillips JR; Herron JG; Severson SJ; Milla CE; Regelmann WE
    J Lab Clin Med; 2004 Sep; 144(3):127-33. PubMed ID: 15454881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial.
    Conrad C; Lymp J; Thompson V; Dunn C; Davies Z; Chatfield B; Nichols D; Clancy J; Vender R; Egan ME; Quittell L; Michelson P; Antony V; Spahr J; Rubenstein RC; Moss RB; Herzenberg LA; Goss CH; Tirouvanziam R
    J Cyst Fibros; 2015 Mar; 14(2):219-27. PubMed ID: 25228446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-derived long-lived oxidants in cystic fibrosis sputum.
    Witko-Sarsat V; Delacourt C; Rabier D; Bardet J; Nguyen AT; Descamps-Latscha B
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1910-6. PubMed ID: 8520754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis.
    Kim JS; Okamoto K; Rubin BK
    Chest; 2006 May; 129(5):1148-54. PubMed ID: 16685004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosis.
    Dauletbaev N; Viel K; Buhl R; Wagner TO; Bargon J
    J Cyst Fibros; 2004 Jun; 3(2):119-24. PubMed ID: 15463894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis.
    Dittrich AS; Kühbandner I; Gehrig S; Rickert-Zacharias V; Twigg M; Wege S; Taggart CC; Herth F; Schultz C; Mall MA
    Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29545279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistin is elevated in cystic fibrosis sputum and correlates negatively with lung function.
    Forrest OA; Chopyk DM; Gernez Y; Brown MR; Conrad CK; Moss RB; Tangpricha V; Peng L; Tirouvanziam R
    J Cyst Fibros; 2019 Jan; 18(1):64-70. PubMed ID: 29937317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis.
    Worlitzsch D; Herberth G; Ulrich M; Döring G
    Eur Respir J; 1998 Feb; 11(2):377-83. PubMed ID: 9551742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase inhibition decreases morbidity and oxidative stress in mice with cystic fibrosis-like lung inflammation.
    Dickerhof N; Huang J; Min E; Michaëlsson E; Lindstedt EL; Pearson JF; Kettle AJ; Day BJ
    Free Radic Biol Med; 2020 May; 152():91-99. PubMed ID: 32142878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study.
    Ordoñez CL; Stulbarg M; Grundland H; Liu JT; Boushey HA
    Pediatr Pulmonol; 2001 Jul; 32(1):29-37. PubMed ID: 11416873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.
    Eickmeier O; Fussbroich D; Mueller K; Serve F; Smaczny C; Zielen S; Schubert R
    PLoS One; 2017; 12(2):e0171249. PubMed ID: 28158236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation increases mucin polymer cross-links to stiffen airway mucus gels.
    Yuan S; Hollinger M; Lachowicz-Scroggins ME; Kerr SC; Dunican EM; Daniel BM; Ghosh S; Erzurum SC; Willard B; Hazen SL; Huang X; Carrington SD; Oscarson S; Fahy JV
    Sci Transl Med; 2015 Feb; 7(276):276ra27. PubMed ID: 25717100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs.
    Hartl D; Starosta V; Maier K; Beck-Speier I; Rebhan C; Becker BF; Latzin P; Fischer R; Ratjen F; Huber RM; Rietschel E; Krauss-Etschmann S; Griese M
    Free Radic Biol Med; 2005 Aug; 39(4):463-72. PubMed ID: 16043018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
    Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
    J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thiol antioxidants on lipopolysaccharide-induced cyclooxygenase-2 expression in pulmonary epithelial cells.
    Choi S; Lim JW; Kim H
    J Physiol Pharmacol; 2018 Aug; 69(4):. PubMed ID: 30415238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development.
    Jain R; Baines A; Khan U; Wagner BD; Sagel SD
    J Cyst Fibros; 2021 Jan; 20(1):50-56. PubMed ID: 32622665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.